JACQUELYN BEEMER: Open Payments
NPI 1396248415 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,117 in 178 payments from 25 companies in 2025. Trend: 2023 $4,682 · 2024 $4,225 · 2025 $3,117
Food & beverage: $3,117
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $392 |
| UCB, Inc. | 16 | $330 |
| Janssen Biotech, Inc. | 13 | $281 |
| LEO Pharma Inc. | 16 | $246 |
| Novartis Pharmaceuticals Corporation | 15 | $236 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $203 |
| Regeneron Healthcare Solutions, Inc. | 6 | $176 |
| Galderma Laboratories, L.P. | 20 | $153 |
| E.R. Squibb & Sons, L.L.C. | 14 | $147 |
| Mallinckrodt Hospital Products Inc. | 2 | $128 |
Products named: Bimzelx, TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, ADBRY, Sotyktu, ACTHAR.
Industry payments across IN — which companies pay providers there.
